<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00921505</url>
  </required_header>
  <id_info>
    <org_study_id>PARIBU-024</org_study_id>
    <secondary_id>EudraCT No. 2009-009036-77</secondary_id>
    <nct_id>NCT00921505</nct_id>
  </id_info>
  <brief_title>Effect of Ibuprofen, Paracetamol and Their Combination on Radical Oxygen Species (ROS) Production</brief_title>
  <official_title>The Effect of Ibuprofen, Paracetamol and Their Combination on Reactive Oxygen Species (ROS)- Production in Leukocytes and Platelet Activation</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Ullevaal University Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>University of Oslo</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Oslo University Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to determine whether paracetamol, ibuprofen or their combination
      can modify generation of radical oxygen species (ROS) from stimulated neutrophils.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Non-steroidal anti-inflammatory drugs (NSAID) are used to alleviate clinical inflammatory
      symptoms (e.g. pain, swelling and reduced function). Leukocytes, upon activation during
      inflammatory states, generate radical oxygen species (ROS) which primarily are intended for
      host defence against invading pathogens. Certain NSAID can modify the generation of ROS from
      stimulated neutrophils ranging form increased production to reduced production. Preliminary
      experiments in our laboratory have shown that different NSAIDs have opposing effects on the
      ability of leukocytes (granulocytes and monocytes) to produce ROS upon a standardized
      stimulus, i.e. phorbol myristate acetate (PMA). Paracetamol has a marked inhibitory effect
      and ibuprofen has a facilitating effect on ROS production. An inhibitory effect of
      paracetamol was also seen when examining platelet activation markers, whereas acetylsalicylic
      acid showed a clear enhancing effect in this respect. We want to examine if intake of
      paracetamol or ibuprofen in vivo have similar effects on leukocyte ROS production and
      platelet activation, respectively.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>May 2009</start_date>
  <completion_date type="Actual">January 2010</completion_date>
  <primary_completion_date type="Actual">January 2010</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <primary_purpose>Basic Science</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Leukocyte radical oxygen species (ROS) production</measure>
    <time_frame>24 hours for each crossover event</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Platelet activation status</measure>
    <time_frame>24 hours for each crossover event</time_frame>
  </secondary_outcome>
  <number_of_arms>4</number_of_arms>
  <enrollment type="Anticipated">7</enrollment>
  <condition>Pain</condition>
  <arm_group>
    <arm_group_label>Ibuprofen 400 mg</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Ibuprofen oral single dose</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Ibuprofen 1200 mg</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Ibuprofen oral single dose</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Paracetamol (acetaminophen) 1000 mg</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Paracetamol (acetaminophen) oral single dose</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Ibuprofen 400 mg + paracetamol 1000 mg</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Paracetamol (acetaminophen) + ibuprofen oral single dose</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Ibuprofen</intervention_name>
    <description>Tablet ibuprofen 400 mg oral single dose (1 tablet)</description>
    <arm_group_label>Ibuprofen 400 mg</arm_group_label>
    <other_name>Ibumetin</other_name>
    <other_name>ATC code: M01A E01</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Ibuprofen</intervention_name>
    <description>Tablets (2 x 600 mg) oral single dose (2 tablets)</description>
    <arm_group_label>Ibuprofen 1200 mg</arm_group_label>
    <other_name>Ibumetin</other_name>
    <other_name>ATC code: M01A E01</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Paracetamol (acetaminophen) 1000 mg</intervention_name>
    <description>Tablets (2 x 500 mg) oral single dose (2 tablets)</description>
    <arm_group_label>Paracetamol (acetaminophen) 1000 mg</arm_group_label>
    <other_name>Paracetamol</other_name>
    <other_name>Acetaminophen</other_name>
    <other_name>ATC code: N02B E01</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Paracetamol + ibuprofen</intervention_name>
    <description>Tablets (ibuprofen 400 mg + paracetamol (acetaminophen) 2 x 500 mg) single oral dose (3 tablets)</description>
    <arm_group_label>Ibuprofen 400 mg + paracetamol 1000 mg</arm_group_label>
    <other_name>Ibumetin</other_name>
    <other_name>Ibuprofen</other_name>
    <other_name>ATC code: M01A E01</other_name>
    <other_name>Paracetamol</other_name>
    <other_name>Acetaminophen</other_name>
    <other_name>ATC code: N02B E01</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Volunteers of both sexes (ASA type I).

          -  Females who are not pregnant or plan conception. (A pregnancy test will be conducted
             before each test day)

          -  Persons who have not used analgesics for 3 days prior to the blood sampling.

          -  Persons without known active peptic ulcer or gastrointestinal bleeding.

          -  Persons without any known hypersensitivity for NSAIDs.

          -  Persons under no other drug treatment than contraceptives.

          -  Age 18 to 35 years of Caucasian origin

        Exclusion Criteria:

          -  Pregnancy during the test period.

          -  Development of active peptic ulcer during the test period.

          -  Change in medication status during the test period (after inclusion).
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>35 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Torstein Lyberg, DDS, MD</last_name>
    <role>Study Director</role>
    <affiliation>Ullevaal University Hospital</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Ullevaal University Hospital</name>
      <address>
        <city>Oslo</city>
        <zip>NO-0407</zip>
        <country>Norway</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Norway</country>
  </location_countries>
  <reference>
    <citation>Stritesky Larssen K, Lyberg T. Oxidative status--age- and circadian variations?--a study in leukocytes/plasma. Neuro Endocrinol Lett. 2006 Aug;27(4):445-52.</citation>
    <PMID>16891997</PMID>
  </reference>
  <reference>
    <citation>Nagata M. Inflammatory cells and oxygen radicals. Curr Drug Targets Inflamm Allergy. 2005 Aug;4(4):503-4. Review.</citation>
    <PMID>16101529</PMID>
  </reference>
  <reference>
    <citation>Nielsen VG, Webster RO. Inhibition of human polymorphonuclear leukocyte functions by ibuprofen. Immunopharmacology. 1987 Feb;13(1):61-71.</citation>
    <PMID>3032852</PMID>
  </reference>
  <verification_date>March 2009</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>June 15, 2009</study_first_submitted>
  <study_first_submitted_qc>June 15, 2009</study_first_submitted_qc>
  <study_first_posted type="Estimate">June 16, 2009</study_first_posted>
  <last_update_submitted>July 3, 2011</last_update_submitted>
  <last_update_submitted_qc>July 3, 2011</last_update_submitted_qc>
  <last_update_posted type="Estimate">July 6, 2011</last_update_posted>
  <responsible_party>
    <name_title>Professor Torstein Lyberg</name_title>
    <organization>Ullevaal University Hospital</organization>
  </responsible_party>
  <keyword>Acetaminophen</keyword>
  <keyword>Ibuprofen</keyword>
  <keyword>Platelets</keyword>
  <keyword>Leukocytes</keyword>
  <keyword>Oxygen species</keyword>
  <keyword>Humans</keyword>
  <keyword>Blood Platelets</keyword>
  <keyword>Reactive Oxygen Species</keyword>
  <keyword>Platelet Activation</keyword>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Acetaminophen</mesh_term>
    <mesh_term>Ibuprofen</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

